Friday, July 29, 2016

Liposomal Bupivacaine After TKA Reduces Hospital Stay

Patients receiving liposomal bupivacaine (Exparel, Pacira) injection after total knee arthroplasty (TKA) spent less time in the hospital and were significantly less likely to need to go to a rehabilitation center after discharge, a recent study found.

Patients given liposomal bupivacaine spent a half-day less in the hospital than those administered routine, opioid-based pain medications, according to the review of patient records by researchers at Philadelphia College of Osteopathic Medicine; Plano Orthopedics and Sports Medicine, in Texas; and the Rubin Institute for Advanced Orthopedics at the Sinai Hospital of Baltimore.


No comments: